A method of reversing, ameliorating or slowing progression of at least one symptom of Lewy body pathology in a patient in need thereof, comprising the step of administering to said patient an amount of one or more hepatocyte growth factor mimics sufficient to reverse, ameliorate or slow progression of said at least one symptom, said one or more hepatocyte growth factor mimics having a general structural formula 1 2 3 wherein Ri is one of an N-acyl group, a substituted or unsubstituted phenyl, a norleucine group, and an amino acid selected from tyrosine, phenylalanine, aspartic acid, arginine, isoleucine, serine, histidine, glycine, cysteine, methionine, tryptophan, lysine norvaline, ornithine, and s-benzyl cysteine
Now you're staring at it wondering if it's still goodor if you just wasted $200 on saline
Gokul PR, Apperley L, Parkinson J, Clark K, Lund K, Owens M, Senniappan S (2025) Semaglutide, a long-acting GLP-1 analogue, for the management of early-onset obesity due to MC4R defect: a case report
Osredkar J
.png)
